Promoter hypermethylation of the RB1 gene in glioblastomas

Laboratory Investigation

Volumn 81, Issue 1, 2001, Pages 77-82

  Nakamura, Mitsutoshi ^a   Yonekawa, Yasuhiro ^b   Kleihues, Paul ^a   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; DNA METHYLATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 0035133842     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780213     Document Type: Article

References (44)

1. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas
2. The retinoblastoma gene in breast cancer: Allele loss is not correlated with loss of gene protein expression
3. Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K-ras gene
4. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas
5. Distinct regions of allelic loss on 13q in prostate cancer
6. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53
7. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma
8. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus
9. Altered retinoblastoma protein expression in nonsmall cell lung cancer: Its synergistic effects with altered ras and p53 protein status on prognosis
10. Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas
11. Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas
12. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma
13. Rb function in cell-cycle regulation and apoptosis
14. The retinoblastoma gene is involved in malignant progression of astrocytomas
15. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
16. Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma
17. 1-S transition control gene abnormalities
18. INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene
19. Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression
20. Primary and secondary glioblastomas: From concept to clinical diagnosis
21. Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: A prospective study
22. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
23. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
24. Immunohistochemical detection of CDKN2, retinoblastoma and p53 gene products in primary astrocytic tumors
25. Arf deletion and methylation in genetic pathways to glioblastomas
26. Loss of heterozygosity on chromosome 19 in secondary glioblastomas
27. CpG methylation inactivates the promoter activity of the human retinoblastoma tumorsuppressor gene
28. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: Evidence for a chromosome 13 tumor suppressor gene other than RB
29. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene
30. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island
31. Chromosome 13q deletion mapping in pituitary tumors: Infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas
32. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors
33. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas
34. The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma
35. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
36. Subsets of glioblastoma multiforme defined by molecular genetic analysis
37. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies
38. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
39. The retinoblastoma protein and cell cycle control
40. Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression
41. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma
42. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma
43. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma